Abstract
Cytochrome P450 (CYP) 1A1 and CYP1B1 are important phase I xenobiotic metabolizing enzymes involved in the metabolism of numbers of toxins, endogenous hormones, and pharmaceutical drugs. Polymorphisms in these phase I genes can alter enzyme activity and are known to be associated with cancer susceptibility related to environmental toxins and hormone exposure. Their genotypes may also display ethnicity-dependent population frequencies. The present study was aimed to determine the frequencies of commonly known functional polymorphisms of CYP1A1 and CYP1B1 genes in a Haryana state population of North India. The allelic frequency of CYP1A1 polymorphism m1 (MspI) was 29.65% and m2 (Ile462Val) was 24.85%. The frequency of CYP1B1 polymorphism m1 (Val432Leu) was 45.85% and m2 (Asn453Ser) was 16.2%. We observed inter- and intra-ethnic variation in the frequency distribution of these polymorphisms. Analysis of polymorphisms in these genes might help in predicting the risk of cancer. Our results emphasize the need for more such studies in high-risk populations.
Similar content being viewed by others
References
Ada AO, Süzen SH, Iscan M (2004) Polymorphisms of cytochrome P450 1A1, glutathione S-transferase M1 and T1 in Turkish population. Toxicol Lett 151:311–315
Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Laughlin R, Nemoto T, Michalek AM, Harrington A, Ford TD, Shields PG (1995) Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 55:3483–3485
Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB (2007) Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 28:1455–1462
Bailey LR, Roodi N, Dupont WD, Parl FF (1998) Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 58:5038–5041
Bosland MC (2000) The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 27:39–66
Buch S, Kotekar A, Kawle D, Bishey R (2001) Polymorphism at CYP and GST gene loci prevalence in Indian population. Eur J Clin Pharmacol 57:553–555
Cascorbi I, Brockmoller J, Roots I (1996) C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages and impact on lung cancer susceptibility. Cancer Res 56:4965–4969
Cosma G, Crofts F, Taioli E, Toniolo P, Garte SJ (1993) The relationship between genotype and function of the human CYPlAl gene. Toxicol Environ Health 40:315–322
Crofts F, Cosma GN, Currie D, Taioli E, Toniolo P, Garte SJ (1993) A novel CYP1A1 gene polymorphism in African–Americans. Carcinogenesis 14:1729–1731
Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P, Garte SJ (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15:2961–2963
Doll R (1998) Uncovering the risk of smoking: historical perspective. Stat Methods Med Res 7:87–117
Garte SJ (1998) The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. Carcinogenesis 19:1329–1332
Garte SJ, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL (2001) Metabolic gene polymorphism frequencies in control population. Cancer Epidemiol Biomarkers Prev 10:1239–1248
Gonzalez FJ (1990) Molecular genetics of the P-450 superfamily. Pharmacol Ther 45:1–38
Gonzalez FJ (2003) Role of gene knockout and transgenic mice in the study xenobiotic metabolism. Drug Metab Rev 35:319–335
Guengerich FP (1999) Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39:1–17
Guengerich FP (2003) Cytochromes P450, drugs, and diseases. Mol Interv 3:194–204
Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF (2000) Cytochrome P4501B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 60:3440–3444
Hayashi SI, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer-associated Mspl polymorphism with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem 110:407–411
Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR (1996) 17-beta estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 93:9776–9781
Inoue K, Asao T, Shimada T (2000) Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations. Xenobiotica 30:285–295
Katoh T, Inatomi H, Nagaoka A, Sugita A (1995) Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. Carcinogenesis (Lond) 16:655–657
Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of cytochrome P4501A1 gene. FEBS Lett 263:131–133
Kumar A, Basavaraj MG, Gupta SK, Qamar I, Ali AM, Bajaj V, Ramesh TK, Prakash DR, Shetty JS, Dorairaj SK (2007) Role of CYP1B1, MYOC, OPTN and OPTC genes in adult-onset primary open-angle glaucoma: predominance of CYP1B1 mutations in Indian patients. Mol Vis 13:667–676
Kumar V, Singh S, Yadav CS, Ahmed RS, Gupta S, Pasha ST, Tripathi AK, Banerjee BD (2009) CYP1A1 and CYP3A4 polymorphic variants in Delhi population of Northern India. Environ Toxicol Pharmacol 28:392–396
Kumar V, Singh S, Ahmed RS, Banerjee BD, Ahmed T, Pasha ST (2010) Frequency of common CYP1B1 polymorphic variations in Delhi population of Northern India. Environ Toxicol Pharmacol 29:120–130
Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, Lau AF (1998) Association of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58:4858–4863
Liehr JG, Ricci MJ (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 93:3294–3296
Majumder PP, Mukherjee BN (1993) Genetic diversity and affinities among Indian populations: an overview. In: Majumder PP (ed) Human population genetics. Plenum Press, New York, pp 255–275
Meyer UA (1994) Pharmacogentics: the slow, the rapid and the ultrarapid. Proc Natl Acad Sci USA 91:1983–1984
Morita S, Yano M, Shiozaki H, Tsujinaka T, Ebisui C, Morimoto T, Kishibuti M, Fujita J, Ogawa A, Taniguchi M, Inoue M, Tamura S, Yamazaki K, Kikkawa N, Mizunoya S, Monden M (1997) CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous cell carcinoma of the esophagus. Int J Cancer 71:192–195
Morita S, Yano M, Tsujinaka T, Akiyama Y, Taniguchi M, Kaneko K, Miki H, Fujii T, Yoshino K, Kusuoka H, Monden M (1999) Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and neck squamous-cell carcinoma. Int J Cancer 80:685–688
Nebert DW, Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155–1162
Nebert DW, Ingelman-Sundberg M, Daly AK (1999) Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues. Drug Metab Rev 31:467–487
Nimura Y, Yokoyama S, Fujimori M, Aoki T, Adachi W, Nasu T, He M, Ping YM, Iida F (1997) Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking. Cancer (Phila) 80:852–857
Pasha SA, Jamil K, Das P (2009) CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Urol J 6:78–86
Rais N, Chawla YK, Kohli KK (2006) CYP3A phenotypes and genotypes in North Indians. Eur J Clin Pharmacol 62:417–422
Roland J, Breton L (1993) Atlas of the languages and ethnic communities of South Asia. Saga, New Delhi, pp 21–39
Sabitha K, Reddy MV, Jamil K (2010) Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer. Cancer Epidemiol 34:587–592
Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR (1996) Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res 56:2979–2984
Singh AP, Shah PP, Mathur N, Buters JT, Pant MC, Parmar D (2008) Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer. Mutat Res 639:11–19
Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A (2004) Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a North Indian population. Mol Cell Biochem 266:1–9
Song N, Tan W, Xing D, Lin D (2001) CYP1A1 polymorphism and risk to lung cancer in relation to tobacco smoking: a case–control study in China. Carcinogenesis 22:11–16
Sowers MR, Wilson AL, Kardia SR, Chu J, McConnell DS (2006) CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal. Am J Med 119:44–51
Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC, Ankathil R (2005) Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 50:618–627
Srivastava DS, Mandhani A, Mittal RD (2008) Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India. Arch Toxicol 82:633–639
Stoilov I, Akarsu AN, Sarfarazi M (1997) Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2P21. Hum Mol Genet 6:641–647
Stoilov I, Akarsu AN, Alozie I, Child A, Barsoum-Homsy M, Turacli ME, Or M, Lewis RA, Ozdemir N, Brice G, Aktan SG, Chevrette L, Coca-Prados M, Sarfarazi M (1998) Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am J Hum Genet 62:573–584
Sutter TR, Tang YM, Hayes CL, Wo YY, Jabs EW, Li X, Yin H, Cody CW, Greenlee WF (1994) Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 269:13092–13099
Tang YM, Wo YY, Stewart J, Hawkins AL, Griffin CA, Sutter TR, Greenlee WF (1996) Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem 271:28324–28330
Tang YM, Green BL, Chen GF, Thompson PA, Lang NP, Shinde A, Lin DX, Tan W, Lyn-Cook BD, Hammons GJ, Kablubar FF (2000) Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls. Pharmacogenetics 10:761–766
Tanimoto K, Hayashi S, Yoshiga K, Ichikawa T (1999) Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol 35:191–196
Vineis P, Lang M, Caporaso N, Cuzick J, Boffetta P (1998) Metabolic polymorphisms and cancer. IARC, Lyon
Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, Wen WQ, Shu XO, Gao YT (2000) Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9:147–150
Acknowledgments
This research was proposed and guided by Dr. Anita Yadav. We are thankful to the University Grant Commission, New Delhi, India, for funding and to all blood donors for their voluntary participation in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giri, S.K., Yadav, A., Kumar, A. et al. Polymorphic Variation of CYP1A1 and CYP1B1 Genes in a Haryana Population. Biochem Genet 51, 853–864 (2013). https://doi.org/10.1007/s10528-013-9612-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-013-9612-y